Tandem Diabetes Care (TNDM) EBT Margin Growth (5y) (2018 - 2026)
Tandem Diabetes Care (TNDM) EBT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Tandem Diabetes Care | 1.14 Bn | 574.71 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -436.00 |
| Dec 31, 2025 | -850.00 |
| Sep 30, 2025 | -251.00 |
| Jun 30, 2025 | 275.00 |
| Mar 31, 2025 | -3,700.00 |
| Dec 31, 2024 | -251.00 |
| Sep 30, 2024 | -628.00 |
| Jun 30, 2024 | -1,178.00 |
| Mar 31, 2024 | 1,422.00 |
| Dec 31, 2023 | -2,082.00 |
| Sep 30, 2023 | 5,747.00 |
| Jun 30, 2023 | 3,172.00 |
| Mar 31, 2023 | -626.00 |
| Dec 31, 2022 | 2,128.00 |
| Sep 30, 2022 | 3,309.00 |
| Jun 30, 2022 | 9,122.00 |
| Mar 31, 2022 | 11,339.00 |
| Dec 31, 2021 | 5,545.00 |
| Sep 30, 2021 | 25,438.00 |
| Jun 30, 2021 | 8,489.00 |